Evidence map›Paper›PMID 20551167›Full record

ArticleGenes & development2010

RB's original CIN?

Julien Sage, Aaron F Straight

Open access · diamondAbstract readComment
In one paragraph

Article in Genes & development, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 35 citations in OpenAlex.

  1. TargetingCancers · 2021
    Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Tumor suppressive pathways in the control of neurogenesis.Cellular and molecular life sciences : CMLS · 2013
    Review
  14. Article
  15. Article
  16. Article
  17. Modeling a lethal prostate cancer variant with small-cell carcinoma features.Clinical cancer research : an official journal of the American Association for Cancer Research · 2012
    Article
  18. Article
  19. Article
  20. Newly identified aspects of tumor suppression by RB.Disease models & mechanisms · 2011
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Julien SageDepartment of Pediatrics, Stanford University, Stanford, California 94305, USA. julsage@stanford.edu
Aaron F Straight
Stanford Medicine · USStanford University · US

Funding

Mechanisms of Kinetochore AssemblyR01GM074728 · NIGMS · STANFORD UNIVERSITY · PI Aaron F Straight · 2005 to 2026
$6.6M
The RB pathway in liver cancerR01CA114102 · NCI · STANFORD UNIVERSITY · PI SAGE, JULIEN · 2006 to 2016
$2.9M
NCI NIH HHS R01 CA114102NCI NIH HHS R01 CA114102-01A1NIGMS NIH HHS GM074728NIGMS NIH HHS R01 GM074728
6 · The paper itself

Abstract

The retinoblastoma tumor suppressor RB is the downstream mediator of a cellular pathway that is thought to prevent cancer by controlling the ability of cells to enter or exit the cell cycle in G0/G1. Recently, however, accumulating evidence has suggested that RB, its family members p107 and p130, and their partners, the E2F family of transcription factors, may have important cellular functions beyond the G1/S transition of the cell cycle, including during DNA replication and at the transition into mitosis. In this issue of Genes & Development, three studies demonstrate a critical role for RB in proper chromosome condensation, centromeric function, and chromosome stability in mammalian cells, and link these cellular functions of RB to tumor suppression in mice. Here we discuss how transcriptional and post-transcriptional mechanisms under the control of the RB pathway ensure accurate progression through mitosis, thereby preventing cancer development.

Indexed as

AnimalsCell Line, TumorChromosomal InstabilityDNA DamageGene Expression Regulation, NeoplasticHumansMutationRetinoblastomaRetinoblastoma ProteinStress, PhysiologicalRetinoblastoma Protein

Identifiers

PMID20551167
PMCPMC2895191
OpenAlexW2084171824

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.